CRP and metabolic syndrome: Higher values of HS-CRP and fibrinogen were associated with higher risks of all outcomes (Fig. 4), and the explained proportions related to these biomarkers were slightly higher than those observed for the metabolic syndrome (Supplementary Figures S9–S10).